2025.10.27
Tokyo, Japan – October 27, 2025 – TCROSS Co., Ltd. is pleased to announce the successful completion of a trial using its proprietary AI-powered sales and marketing optimization system, InsighTCROSS, in the field of rare diseases.
InsighTCROSS integrates pharmaceutical companies’ internal market, customer, and sales data to calculate prescription probabilities, identify target physicians, determine key drivers of prescription behaviour, and conduct ROI analysis—all aimed at optimizing commercial strategies.
TCROSS Co., Ltd. is a Tokyo-based healthcare data analytics company specializing in AI-powered solutions for pharmaceutical marketing optimization. Its flagship product, InsighTCROSS, supports pharmaceutical and medical device companies in improving commercial efficiency and maximizing the impact of marketing investments through evidence-based decision-making.
Media Contact:
TCROSS Co., Ltd.
E-mail：webmaster＠tcross.co.jp
Website：
https://company.tcross.co.jp/en/index.html